Literature DB >> 15261875

Characterization of ataxias with magnetic resonance imaging and spectroscopy.

Martin Viau1, Yvan Boulanger.   

Abstract

A wide variety of autosomal transmitted ataxias exist and their ultimate characterization requires genetic testing. Common clinical characteristics among different ataxia types complicate the choice of the appropriate genetic test. Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) generally show cerebellar or cerebral atrophy and perturbed metabolite levels which differ between ataxias. In order to help the clinician accurately identify the ataxia type, reported MRI and MRS data in different brain regions are summarized for more than 60 different types of autosomal inherited and sporadic ataxias.

Entities:  

Mesh:

Year:  2004        PMID: 15261875     DOI: 10.1016/j.parkreldis.2004.02.006

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  6 in total

Review 1.  Spinocerebellar ataxias: prospects and challenges for therapy development.

Authors:  Tetsuo Ashizawa; Gülin Öz; Henry L Paulson
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

2.  Proton spectroscopy and imaging at 3T in ataxia-telangiectasia.

Authors:  L I Wallis; P D Griffiths; S J Ritchie; C A J Romanowski; G Darwent; I D Wilkinson
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

3.  Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy.

Authors:  Gülin Oz; Isabelle Iltis; Diane Hutter; William Thomas; Khalaf O Bushara; Christopher M Gomez
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

4.  In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7.

Authors:  Isaac M Adanyeguh; Pierre-Gilles Henry; Tra M Nguyen; Daisy Rinaldi; Celine Jauffret; Romain Valabregue; Uzay E Emir; Dinesh K Deelchand; Alexis Brice; Lynn E Eberly; Gülin Öz; Alexandra Durr; Fanny Mochel
Journal:  Mov Disord       Date:  2015-03-15       Impact factor: 10.338

5.  Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status.

Authors:  Gülin Oz; Diane Hutter; Ivan Tkác; H Brent Clark; Myron D Gross; Hong Jiang; Lynn E Eberly; Khalaf O Bushara; Christopher M Gomez
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

6.  Is 1H-MR spectroscopy useful as a diagnostic aid in MSA-C?

Authors:  Viren H Kadodwala; Marios Hadjivassiliou; Stuart Currie; Nicholas Skipper; Nigel Hoggard
Journal:  Cerebellum Ataxias       Date:  2019-07-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.